CHOSENMED

chosenmed-logo

ChosenMed is a healthcare company in oncology precision medicine, focusing on early tumor screening and companion diagnosis.

#SimilarOrganizations #People #Financial #Website #More

CHOSENMED

Industry:
Health Care Health Diagnostics Medical

Founded:
2018-01-01

Address:
Beijing, Beijing, China

Country:
China

Website Url:
http://www.chosenmedtech.com

Total Employee:
1+

Status:
Active

Contact:
+86 010-59544150

Email Addresses:
[email protected]

Total Funding:
14 M USD

Technology used in webpage:
SPF Euro Pound Sterling Japanese Yen Alibaba Tencent QQ Mail


Similar Organizations

infervision-logo

Infervision

Infervision is an AI high-tech company that uses deep learning technology and computer vision to help diagnose cancers.

medbanks-logo

Medbanks

Medbanks is a database platform of clinical and professional medical services for clinical oncology.

new-horizon-health-logo

New Horizon Health

New Horizon Health is a bio-tech company focusing on early screening and genetic testing services for high-incidence cancer homes.

knopp-biosciences-logo

Knopp Biosciences

Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.

practo-logo

Practo

Practo is an mhealth platform that connects patients with healthcare providers through booking appointments, check-ups, and consultations.

redcliffe-labs-logo

Redcliffe Labs

Redcliffe is a one-stop diagnostic platform offering a wide selection of tests to choose from and delivering care closer to the customer.

Current Employees Featured

qiming-zhou_image

Qiming Zhou
Qiming Zhou Founder & Chief Executive Officer & Chief Technology Officer @ ChosenMed
Founder & Chief Executive Officer & Chief Technology Officer

Founder


qiming-zhou_image

Qiming Zhou

Investors List

yijing-capital_image

Yijing Capital

Yijing Capital investment in Series C - ChosenMed

jingming-capital_image

Jingming Capital

Jingming Capital investment in Series C - ChosenMed

highlight-capital-llc_image

Highlight Capital

Highlight Capital investment in Series B - ChosenMed

delta-capital-2_image

Delta Capital

Delta Capital investment in Series B - ChosenMed

hy-capital_image

HY Capital

HY Capital investment in Series B - ChosenMed

med-fine-capital_image

Med-Fine Capital

Med-Fine Capital investment in Series B - ChosenMed

shanghai-alliance-investment_image

Shanghai Alliance Investment

Shanghai Alliance Investment investment in Series B - ChosenMed

med-fine-capital_image

Med-Fine Capital

Med-Fine Capital investment in Series A - ChosenMed

highlight-capital-llc_image

Highlight Capital

Highlight Capital investment in Series A - ChosenMed

delta-capital-2_image

Delta Capital

Delta Capital investment in Series A - ChosenMed

Official Site Inspections

http://www.chosenmedtech.com Semrush global rank: 7.25 M Semrush visits lastest month: 548

  • Host name: 123.57.221.41
  • IP address: 123.57.221.41
  • Location: Hangzhou China
  • Latitude: 30.294
  • Longitude: 120.1619
  • Timezone: Asia/Shanghai

Loading ...

More informations about "ChosenMed"

ChosenMed - Crunchbase Company Profile & Funding

Organization. ChosenMed . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact Email …See details»

求臻医学

求臻医学成立于2017年,以新一代基因测序和先进信息挖掘技术为基础,依托《中国肿瘤基因图谱计划》和《肿瘤精准医学大数据平台》项目,深度融合基因检测和人工智能,致力于肿瘤液态 …See details»

求臻医学 - 求臻医学 - chosenmedtech.com

求臻医学成立于2017年,以新一代基因测序和先进信息挖掘技术为基础,依托《中国肿瘤基因图谱计划》和《肿瘤精准医学大数据平台》项目,深度融合基因检测和人工智能,致力于肿瘤液态 …See details»

ChosenMed Company Profile 2024: Valuation, Funding & Investors …

ChosenMed General Information Description. Developer of oncology products covering the fields of early screening, prevention and diagnosis of tumors. The company focuses on guidance of …See details»

求臻医学企业简介 - 新闻中心 - 求臻医学 - chosenmedtech.com

求臻医学科技(浙江)有限公司(ChosenMed Technology (Zhejiang) Co., Ltd)(简称:求臻医学)成立于2017年11月23日,所属行业为生物医药——体外诊断(IVD),是一家专注肿瘤精准 …See details»

ChosenMed - Products, Competitors, Financials, Employees, …

Age and BRAFV600E Mutation Stratified Patients with Cytologically Benign Thyroid Nodules. Dec 22, 2023. Guocong Huang,1 Wei Liu,2 Li Han,2 Yue Zhang,2 Siyao Liu,2 Jiali Zhang,2 …See details»

ChosenMed - Company Profile - Tracxn

6 days ago ChosenMed - Provider of a wide range of genomic services. Raised a total funding of $14.1M over 4 rounds from 10 investors. Founded by Zhou Qiming and Wang Dongliang in the …See details»

求臻医学科技(北京)有限公司:官网、创业项目及相关资讯

Apr 20, 2020 求臻医学科技(北京)有限公司,现为国家高新技术企业,国家医疗健康大数据中心成员单位;以生物信息学和高通量测序技术为手段,全面布局肿瘤液态活检领域,为肿瘤患 …See details»

ChosenMed Technology - Overview, News & Competitors

View ChosenMed Technology (www.chosenmedtech.com) location , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»

ChosenMed Technology Co., Ltd. - CMOCRO - Domain Name

ChosenMed Technology is a national high-tech enterprise, that harnesses cutting-edge techniques like next-generation sequencing and advanced information mining. The …See details»

求臻医学科技 (北京)有限公司-Q医疗·医疗信息化平台

求臻医学致力于成为全球领先的肿瘤精准医学全流程产品及服务提供商,产品覆盖肿瘤早期筛查、预防和诊断、动态监测、用药指导、预后评估及生物信息学大数据分析等领域。See details»

ChosenMed - Golden

ChosenMed is a Beijing-based company founded in 2018 by Qiming Zhou. Overview Structured Data Issues Contributors Activity. ContentsSee details»

ChosenMed (求臻医学) - Team members, CEO, Employees

ChosenMed (求臻医学) is a provider of oncology products and services, covering precision medicine solutions including early tumor screening, prevention and diagnosis, dynamic …See details»

求臻医学信息平台官网

求臻医学信息平台 ChosenMedInfo. A medical information platform independently developed by the medical information team focusing on the precise diagnosis and treatment of cancer.See details»

技术实力 - 求臻医学 - chosenmedtech.com

全球首个基于NGS检测MSI状态,最为广泛且权威的算法软件,拥有FDA批准的生物信息分析核心软件。 MSIsensor\MSIsensor2\ MSIsensor-ct系列算法已应用于超过29个国家的670个基因检 …See details»

OncoCTMiner - an oncology trial eligibility pre-screening solution ...

Cite Us: Xu, Q., Liu, Y., Sun, D., Huang, X., Li, F., Zhai, J., ... & Niu, B. (2023). OncoCTMiner: streamlining precision oncology trial matching via molecular ...See details»

产品服务 - 求臻医学 - chosenmedtech.com

求臻医学自主研发了二十余款针对不同癌种的Chosen系列肿瘤伴随诊断及早筛检测产品. 致力于肿瘤液态活检领域诊断产品的开发及智能迭代升级,业务涵盖肿瘤早筛、伴随诊断、动态监测、 …See details»

NGDC - GSA for Human - National Genomics Data Center

The Performance of Homopolymer Detection Using Dichromatic and Tetrachromatic Fluorogenic Next-Generation Sequencing PlatformsSee details»

官宣!求臻医学ChosenOne®MRD产品正式上线 - 新闻中心 - 求臻 …

求臻医学以新一代基因测序和先进信息挖掘技术为基础,深度融合检测技术和人工智能,致力于探索科技创新及产品的开发和 ...See details»

肿瘤临床检测 - 求臻医学 - chosenmedtech.com

精准诊断,检测先行,求臻医学的肿瘤基因检测产品同时涵盖实体肿瘤和血液肿瘤,持续基于深厚的技术底蕴及优质的产品服务,让更多肿瘤患者获益,引领精准医疗产业发展。See details»

linkstock.net © 2022. All rights reserved